(Q61790695)
Statements
Safety of discontinuation of maintenance therapy for disseminated histoplasmosis after immunologic response to antiretroviral therapy (English)
Constantin T Yiannoutsos
Judith A Aberg
Susan L Koletar
Mitchell Goldman
Robert Zackin
Daniel J Skiest
Richard Hafner
L Joseph Wheat
Peter M Nyangweso
Carol T Schnizlein-Bick
Susan Owens
AIDS Clinical Trials Group A5038 Study Group